Venker Eric (CIK 1801917) reported 84 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-09-01). Recent activity: Buy ROIV (200,000 shares), Sell ROIV (166,182 shares), Sell ROIV (33,818 shares), Sell ROIV (13,909 shares), Buy ROIV (200,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-01 | Roivant Sciences Ltd. (ROIV) | President & Immunovant CEO | Buy | 200,000 | $770,000 |
| 2026-09-01 | Roivant Sciences Ltd. (ROIV) | President & Immunovant CEO | Sell | 166,182 | $5.9M |
| 2026-09-01 | Roivant Sciences Ltd. (ROIV) | President & Immunovant CEO | Sell | 33,818 | $1.2M |
| 2026-08-24 | Roivant Sciences Ltd. (ROIV) | President & Immunovant CEO | Sell | 13,909 | $512,408 |
| 2026-07-29 | Roivant Sciences Ltd. (ROIV) | President & Immunovant CEO | Buy | 200,000 | $770,000 |
| 2026-07-29 | Roivant Sciences Ltd. (ROIV) | President & Immunovant CEO | Sell | 200,000 | $7.0M |
| 2026-07-06 | Immunovant, Inc. (IMVT) | Chief Executive Officer | Buy | 92,188 | $1.3M |
| 2026-07-06 | Immunovant, Inc. (IMVT) | Chief Executive Officer | Sell | 86,629 | $3.3M |
| 2026-07-06 | Immunovant, Inc. (IMVT) | Chief Executive Officer | Sell | 3,092 | $118,980 |
| 2026-06-26 | Roivant Sciences Ltd. (ROIV) | President & Immunovant CEO | Buy | 200,000 | $770,000 |
| 2026-06-26 | Roivant Sciences Ltd. (ROIV) | President & Immunovant CEO | Sell | 153,766 | $5.1M |
| 2026-06-26 | Roivant Sciences Ltd. (ROIV) | President & Immunovant CEO | Sell | 46,234 | $1.5M |
| 2026-05-22 | Roivant Sciences Ltd. (ROIV) | President & Immunovant CEO | Sell | 34,483 | $1.1M |
| 2026-05-22 | Roivant Sciences Ltd. (ROIV) | President & Immunovant CEO | Buy | 200,000 | $770,000 |
| 2026-05-22 | Roivant Sciences Ltd. (ROIV) | President & Immunovant CEO | Sell | 200,000 | $6.1M |
| 2026-04-22 | Roivant Sciences Ltd. (ROIV) | President & Immunovant CEO | Sell | 200,000 | $5.9M |
| 2026-04-22 | Roivant Sciences Ltd. (ROIV) | President & Immunovant CEO | Buy | 200,000 | $770,000 |
| 2026-04-09 | Immunovant, Inc. (IMVT) | Chief Executive Officer | Buy | 232,252 | $0 |
| 2026-04-03 | Immunovant, Inc. (IMVT) | Chief Executive Officer | Buy | 368,750 | $5.3M |
| 2026-04-03 | Immunovant, Inc. (IMVT) | Chief Executive Officer | Sell | 334,960 | $8.4M |
| 2026-04-03 | Immunovant, Inc. (IMVT) | Chief Executive Officer | Sell | 12,820 | $308,193 |
| 2026-04-03 | Immunovant, Inc. (IMVT) | Chief Executive Officer | Sell | 1,409 | $34,661 |
| 2026-03-19 | Roivant Sciences Ltd. (ROIV) | President & Immunovant CEO | Buy | 200,000 | $770,000 |
| 2026-03-19 | Roivant Sciences Ltd. (ROIV) | President & Immunovant CEO | Sell | 200,000 | $5.6M |
| 2026-02-24 | Roivant Sciences Ltd. (ROIV) | President & Immunovant CEO | Sell | 7,051 | $191,435 |
来源：SEC Form 4 申报文件 · 截至 2026-09-01